Pro-angiogenic Activity Discriminates Human Adipose-Derived Stromal Cells From Retinal Pericytes: Considerations for Cell-Based Therapy of Diabetic Retinopathy-Reference-Cited by-同舟云学术

Pro-angiogenic Activity Discriminates Human Adipose-Derived Stromal Cells From Retinal Pericytes: Considerations for Cell-Based Therapy of Diabetic Retinopathy

Published:2020-06-09 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Kremer Heiner,Gebauer Julian,Elvers-Hornung Susanne,Uhlig Stefanie,Hammes Hans-Peter,Beltramo Elena,Steeb Lothar,Harmsen Martin C.,Sticht Carsten,Klueter Harald,Bieback Karen,Fiori Agnese

Funder

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference60 articles.

1. Extracellular vesicles derived from mesenchymal stem cells induce features of diabetic retinopathy in vitro.;Beltramo;Acta Diabetol.,2014

2. Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes.;Beltramo;Diabetes Metab. Res. Rev.,2009

3. Pericyte loss in diabetic retinopathy: mechanisms and consequences.;Beltramo;Curr. Med. Chem.,2013

4. The role of pericytes in blood-vessel formation and maintenance.;Bergers;Neuro Oncol.,2005

5. Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum.;Bieback;Cytotherapy,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormalities of retinal function in type 2 diabetes mellitus patients without clinical diabetic retinopathy detected by multifocal electroretinogram;BMC Ophthalmology;2024-02-15

2. Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality;Journal of Translational Medicine;2023-10-16

3. Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality;2023-08-19

4. Mesenchymal stem cells therapy for retinal diseases;The Eye, Volume 4;2023

5. The abnormality of retinal function in early type 2 diabetes patients without retinopathy;2022-11-21